HomeNewsBusinessVisa delays inhibiting recovery of air traffic between India & UK: Virgin Atlantic’s Alex McEwan

Visa delays inhibiting recovery of air traffic between India & UK: Virgin Atlantic’s Alex McEwan

But in spite of visa troubles, most of Virgin Atlantic's India-UK flights have been operating with high passenger loads. And corporate travel has bounced back to pre-Covid levels.

October 20, 2022 / 20:13 IST
Story continues below Advertisement

Virgin Atlantic expects international traffic between India and the UK to grow even more once visa issues between the two countries are resolved, the airline's India head Alex McEwan told Moneycontrol.

McEwan said that despite the delays in visa approvals, most of Virgin Atlantic's India-UK flights have been operating with high passenger loads, but added that the market could grow even more once these issues were resolved.

Story continues below Advertisement

He added that corporate travel between the two countries was back to pre-Covid levels, and that India had emerged as the third-largest market for Virgin Atlantic, after the UK and the USA.

Edited Excerpts:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show